Chwalba A, Dudek A, Otto-Buczkowska E
Butrick CW, Howard FM, Sand PK
Kataria S, Tandon M, Melnic V, Sriwastava S (2020) A case series and literature review of multiple sclerosis and COVID-19: clinical characteristics, outcomes and a brief review of immunotherapies
Unfortunately, there is no way of knowing how a medicine will affect you until you begin to take it, but this is why GLP-1 receptor agonists are generally titrated up to the therapeutic dose over the course of several weeks, as it reduces the risk of experiencing severe or debilitating side effects
However, roughly half of the people using these drugs discontinue them within 1 year
Mention it to your coordinator before your cycle begins, not after